Merck KGaA (MRK) News Today €135.50 -0.95 (-0.70%) As of 02/21/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period MRK INVESTOR DEADLINE: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 20 at 4:12 PM | markets.businessinsider.comMerck wins EU nod for Welireg against two kidney cancer indicationsFebruary 19 at 4:49 AM | seekingalpha.comMerck downgraded to Hold from Buy at Deutsche BankFebruary 18, 2025 | markets.businessinsider.comDeutsche downgrades Merck ahead of Keytruda 2028 expirationFebruary 18, 2025 | markets.businessinsider.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRKFebruary 14, 2025 | markets.businessinsider.comMerck & Company, Inc. (MRK) Stock ForecastsFebruary 13, 2025 | finance.yahoo.comGermany's Merck in Advanced Talks to Acquire US Biotech Firm SpringWorksFebruary 11, 2025 | msn.comSpringWorks Therapeutics jumps on report of Merck KGaA takeover talks (update)February 11, 2025 | seekingalpha.comMerck stock price target lowered to $95 by Bernstein SocGenFebruary 11, 2025 | msn.comMerck price target lowered to $112 from $118 at BofAFebruary 5, 2025 | markets.businessinsider.comWells Fargo Remains a Hold on Merck & Company (MRK)February 5, 2025 | markets.businessinsider.comMerck KGaA (ETR:MRK) Shares Up 2% - Time to Buy?Merck KGaA (ETR:MRK) Trading Up 2% - What's Next?February 1, 2025 | marketbeat.comMerck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in AdultsJanuary 31, 2025 | uk.finance.yahoo.comMerck’s capvaxive receives positive EU CHMP opinion for pneumococcal vaccineJanuary 31, 2025 | markets.businessinsider.comMerck's CAPVAXIVE Gets Positive EU CHMP Opinion For Pneumococcal Vaccination In AdultsJanuary 31, 2025 | markets.businessinsider.comMerck gets priority review for Welireg for PPGLJanuary 27, 2025 | seekingalpha.comMerck's SWOT analysis: stock outlook amid oncology competition, pipeline growthJanuary 25, 2025 | msn.comMerck, Eisai post mixed Phase 3 data for Keytruda/ Lenvima in GIT cancerJanuary 24, 2025 | msn.comMerck price target lowered to $113 from $123 at Morgan StanleyJanuary 21, 2025 | markets.businessinsider.comAnalysts Are Neutral on These Healthcare Stocks: Inspire Medical Systems (INSP), Merck & Company (MRK)January 21, 2025 | markets.businessinsider.comWhat's In Store For Merck Stock In 2025?January 17, 2025 | forbes.comBerenberg Bank Remains a Buy on Merck & Company (MRK)January 15, 2025 | markets.businessinsider.comMerck & Co.’s Accelerated Keytruda Launch and Strategic Updates Bolster Long-term Growth ProspectsJanuary 14, 2025 | markets.businessinsider.comMerck Races to Launch Subcutaneous Keytruda Amid Looming Patent Expiry for IV VersionJanuary 14, 2025 | uk.finance.yahoo.comMerck KGaA (ETR:MRK) Shares Down 1.4% - What's Next?Merck KGaA (ETR:MRK) Shares Down 1.4% - Here's WhyJanuary 10, 2025 | marketbeat.comEQS-AFR: Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statementsJanuary 9, 2025 | markets.businessinsider.comMerck’s Gardasil receives expanded approval for males in ChinaJanuary 8, 2025 | markets.businessinsider.comMerck downgraded to Hold from Buy at TruistJanuary 7, 2025 | markets.businessinsider.comTruist Financial downgrades Merck & Company (MRK) to a HoldJanuary 7, 2025 | markets.businessinsider.comUnpacking the Latest Options Trading Trends in Merck & CoJanuary 7, 2025 | benzinga.comWuxi Biologics to sell Irish vaccine facility to Merck for $500M, Reuters saysJanuary 7, 2025 | markets.businessinsider.comMerck launches first-to-market, cyber-physical trust platform to tackle issues of product safety and counterfeitingJanuary 7, 2025 | finanznachrichten.deMerck KGaA, Darmstadt, Germany, launches first-to-market, cyber-physical trust platform to tackle issues of product safety and counterfeitingJanuary 7, 2025 | tmcnet.comMerck put volume heavy and directionally bearishJanuary 2, 2025 | markets.businessinsider.comMerck’s sotatercept approved by MHRA to treat PAHDecember 31, 2024 | markets.businessinsider.comMerck KGaA's (ETR:MRK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?December 26, 2024 | finance.yahoo.comMerck closes exclusive global license agreement for LM-299 from LaNova MedicinesDecember 20, 2024 | markets.businessinsider.comBMO Capital Downgrades Merck (MRK)December 20, 2024 | msn.comMerck Reports Topline Data From Phase 3 Trials Of Doravirine + Islatravir To Treat HIV-1 InfectionDecember 19, 2024 | markets.businessinsider.comMerck: FDA To Review BLA For Clesrovimab - Quick FactsDecember 17, 2024 | markets.businessinsider.comMerck announces approval of KEYTRUDA in China in combination with chemotherapyDecember 16, 2024 | markets.businessinsider.comMerck announces CHMP opinion recommending conditional approval of WeliregDecember 13, 2024 | markets.businessinsider.comMerck gets positive EU regulatory opinion for WeliregDecember 13, 2024 | msn.comBoulder drug discovery co. attracts Merck as an investorDecember 11, 2024 | bizjournals.comIs Merck & Co., Inc. (MRK) the Best American Dividend Stock to Buy Right Now?December 11, 2024 | msn.comWhy former Merck VP left big biotech for this Seattle startupDecember 10, 2024 | bizjournals.comMerck says Phase 3 KEYLYNK-001 trial met primary endpointDecember 10, 2024 | markets.businessinsider.comMerck Announces Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Advanced Epithelial Ovarian CancerDecember 10, 2024 | finance.yahoo.comMerck reports mixed results from Keytruda ovarian cancer studyDecember 10, 2024 | msn.comWhy Merck & Co. (MRK) Is Among the Best Affordable Stocks to Buy Right NowDecember 6, 2024 | msn.com Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address MRK Media Mentions By Week MRK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.170.60▲Average Medical News Sentiment MRK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼43▲MRK Articles Average Week Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MorphoSys News Today ad pepper media International News Today Genfit News Today Evotec News Today Siemens Healthineers News Today Bayer Aktiengesellschaft News Today Fresenius Medical Care News Today Carl Zeiss Meditec News Today Gerresheimer News Today CompuGroup Medical SE & Co. KGaA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MRK) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
